Lupin said it has acquired diabetes brands Ondero (linagliptin) and Ondero Met (linagliptin and metformin) from Boehringer Ingelheim including the trademark rights associated with these brands for 26 million euros (Rs...
ChrysCapital still in race to buy controlling stake in Glenmark Life Sciences
Private equity (PE) firm ChrysCapital remains firmly in the race to acquire Glenmark Pharma’s stake in Glenmark Life Sciences (GLS), with reports about detergent-to-chemicals maker Nirma closing on the deal doing...
Novo Nordisk to acquire obesity drug developer Inversago
Danish drug maker Novo Nordisk said it would acquire Canadian company Inversago Pharma in a $1.07 billion deal including the development of an appetite regulator. Inversago is a privately owned company which develops...
Blackstone sets its sights on buying out Hamieds from Cipla
Blackstone, the world’s largest private equity fund, is set to submit a non-binding bid as early as next week to acquire the entire 33.47% promoter stake in Cipla, India’s third-largest generics company by revenues...
Strides sells arm’s manufacturing unit to Syngene International for Rs 702 crore
Strides Pharma Science on Monday said it has entered into a binding agreement to sell biologics Unit-3 manufacturing facility of its associate company Stelis Biopharma (SBL) to Syngene International on a slump sale...
CORONA remedies buys Sanofi India’s ortho brand Myoril
Ahmedabad-based pharmaceutical company CORONA Remedies has acquired leading muscle relaxant brand Myoril from Sanofi India, for Rs234 crore. Corona has acquired Myoril (Thiocolchicoside) and its extensions such as...
Zydus picks 6.5% in Mylab from Adar Poonawala co for ₹106 Cr
Zydus Lifesciences, said through its wholly-owned subsidiary Zydus Animal Health & Investments (ZAHIL), it has acquired 6.5% stake in Pune-based Mylab Discovery Solutions from Rising Sun Holdings, an investment...
PAG to pick minority stake in RK Pharma
Asian investment firm PAG plans to acquire a significant minority stake in speciality injectables company RK Pharma Inc. and its subsidiaries, according to people familiar with the deal. Besides secondary shares sales...
Eiko Lifesciences acquires 25.01% stake in Reflux Pharmaceuticals
Eiko LifeSciences Limited (ELL), announced that it has acquired a 25.01 per cent stake in Reflux Pharmaceuticals Private Limited (RPPL), a pharmaceutical company that specialises in manufacturing and exporting active...
Spanish pharmaceutical firm Esteve sells 26% stake to Germany’s Lubea
Spanish pharmaceuticals company Esteve has agreed to sell a 26% stake to German private investment firm Lubea, which will become a strategic partner, the family-owned firm based in Barcelona said in a statement on...
Pfizer plans $31 bln debt offering to fund Seagen takeover
Pfizer Inc said it plans to raise $31 billion from a debt offering to finance its proposed acquisition of Seagen Inc. Pfizer struck a $43 billion deal in March to acquire Seagen and its targeted cancer therapies as it...
Sanofi India board OKs demerger of consumer health business
Sanofi India said its board has approved the demerger of consumer health business into its proposed wholly-owned subsidiary Sanofi Consumer Healthcare India (SCHIL), subject to the approval of Sanofi India’s...
